Form 8-K - Current report:
SEC Accession No. 0001437749-22-022258
Filing Date
2022-09-13
Accepted
2022-09-13 08:45:34
Documents
29
Period of Report
2022-09-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K nby20220909_8k.htm   iXBRL 8-K 86820
2 EXHIBIT 3.1 ex_422212.htm EX-3.1 121858
3 EXHIBIT 4.1 ex_422213.htm EX-4.1 106334
4 EXHIBIT 4.2 ex_422214.htm EX-4.2 110307
5 EXHIBIT 4.3 ex_422215.htm EX-4.3 103050
6 EXHIBIT 4.4 ex_422216.htm EX-4.4 104071
7 EXHIBIT 4.5 ex_422217.htm EX-4.5 105772
8 EXHIBIT 4.6 ex_422218.htm EX-4.6 106281
9 EXHIBIT 10.1 ex_422219.htm EX-10.1 81247
10 EXHIBIT 10.2 ex_422220.htm EX-10.2 79070
11 EXHIBIT 10.3 ex_422221.htm EX-10.3 266451
12 EXHIBIT 10.4 ex_422222.htm EX-10.4 160075
13 EXHIBIT 10.5 ex_422223.htm EX-10.5 7562
14 EXHIBIT 10.6 ex_422224.htm EX-10.6 22404
15 EXHIBIT 10.7 ex_422225.htm EX-10.7 25831
16 EXHIBIT 99.1 ex_422226.htm EX-99.1 20724
21 logo01.jpg GRAPHIC 9343
  Complete submission text file 0001437749-22-022258.txt   1994145

Data Files

Seq Description Document Type Size
17 XBRL TAXONOMY EXTENSION SCHEMA nby-20220909.xsd EX-101.SCH 3593
18 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nby-20220909_def.xml EX-101.DEF 11529
19 XBRL TAXONOMY EXTENSION LABEL LINKBASE nby-20220909_lab.xml EX-101.LAB 15414
20 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nby-20220909_pre.xml EX-101.PRE 11685
23 EXTRACTED XBRL INSTANCE DOCUMENT nby20220909_8k_htm.xml XML 2567
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

EIN.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33678 | Film No.: 221239794
SIC: 2834 Pharmaceutical Preparations